COMT and breast cancer: However, despite preliminary in vitro findings suggesting that the mutant COMT-Met isoforms may increase BC risk due to variations in COMT catalytic activity associated with significant differences in the level of catechol estrogens [58], the role of COMT polymorphisms in BC risk has not yet been established, as results of several studies have been inconclusive or controversial [59,60].